CD8 T cells are one of the primary tumor-infiltrating immune cells that produce IFN-γ; they thereby contribute to an inflammatory environment that favors antitumor immunity and modifies the clinical response in cancer immunotherapies [25, 26]. This evidence concerns the gene CD8A and cancer.